跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Enoxbicare-40 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Enoxbicare-40
Approved
STANDARD
Enoxbicare-40
Brawn Laboratories Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
193ff1939459bda0
Company
Brawn Laboratories Ltd.
Type
Standard
Approval Details
Approval Id
193ff1939459bda0
Drug Approval Philippines Name
Enoxbicare-40
Product Name
Enoxbicare-40
Registration Number
BR-041-03
Brand Name
Enoxbicare-40
Generic Name
Enoxaparin Sodium
Dosage Form
Solution For Injection (SC)
Dosage Strength
4000 IU Anti-Factor Xa (equivalent to 40 mg) / 0.4 mL
Manufacturer
Brawn Laboratories Ltd.
Importer
Ambica International Corporation
Distributor
Ambicare Pharmaceuticals Inc.
Issuance Date
25 April 2022
Expiry Date
09 December 2025
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
193ff1939459bda0
Type
Standard
Back to Philippines FDA Approvals